Pacific Biosciences Of California (PACB) Current Leases (2019 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly Current Leases of $277000.0 for Q1 2026, down 88.54% year-over-year from $2.4 million in Q1 2025, and down 38.17% quarter-over-quarter from $448000.0 in Q4 2025.
Pacific Biosciences Of California (PACB) Current Leases (2019 - 2026) Analysis & Trends
Pacific Biosciences Of California's Current Leases history runs 8 years deep, the most recent figure standing at $277000.0 for Q1 2026.
- In Q1 2026, Current Leases fell 88.54% year-over-year to $277000.0; the TTM figure through Mar 2026 stood at $277000.0 (down 88.54% YoY), while the FY2025 annual figure was $448000.0, down 95.53% from the prior year.
- Current Leases for Q1 2026 stood at $277000.0, down from $448000.0 in the prior quarter.
- The five-year high for Current Leases was $12.5 million in Q2 2024, with the low at $277000.0 in Q1 2026.
- The 5-year median for Current Leases is $8.9 million (2022), against an average of $7.0 million.
- The sharpest annual moves came in 2022 and 2025: Current Leases soared 81.12% in 2022, then plunged 95.53% in 2025.
- Pacific Biosciences Of California's Current Leases stood at $8.9 million in 2022, then gained by 7.93% to $9.6 million in 2023, then grew by 4.54% to $10.0 million in 2024, then slumped by 95.53% to $448000.0 in 2025, then sank by 38.17% to $277000.0 in 2026.
- Business Quant data shows PACB's Current Leases at $277000.0 in Q1 2026, $448000.0 in Q4 2025, and $621000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn | - |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn | - |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | 24.10 Mn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | 20.70 Mn |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn | - |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | 35.60 Mn |
| 10 | Pacific Biosciences Of California | 396.09 Mn | 159.21 Mn | 12.64 Mn | 1.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.37 Mn |
| Mar 31, 2026 | 277,000.00 |
| Dec 31, 2025 | 448,000.00 |
| Sep 30, 2025 | 621,000.00 |
| Jun 30, 2025 | 703,000.00 |
| Mar 31, 2025 | 2.42 Mn |
| Dec 31, 2024 | 10.03 Mn |
| Sep 30, 2024 | 10.68 Mn |
| Jun 30, 2024 | 12.49 Mn |
| Mar 31, 2024 | 9.77 Mn |
| Dec 31, 2023 | 9.59 Mn |
| Sep 30, 2023 | 9.46 Mn |
| Jun 30, 2023 | 9.24 Mn |
| Mar 31, 2023 | 9.02 Mn |
| Dec 31, 2022 | 8.89 Mn |
| Sep 30, 2022 | 8.61 Mn |
| Jun 30, 2022 | 8.35 Mn |
| Mar 31, 2022 | 8.06 Mn |
| Dec 31, 2021 | 7.71 Mn |
| Jun 30, 2021 | 4.64 Mn |